Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
This report contains market size and forecasts of CAR T-Cell Therapy in Global, including the following market information:
Global CAR T-Cell Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global CAR T-Cell Therapy market was valued at 1770.5 million in 2022 and is projected to reach US$ 10330 million by 2030, at a CAGR of 28.7% during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
CD19 - Targeted Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CAR T-Cell Therapy include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, CARsgen Therapeutics (Pipeline), Autolus Therapeutics(Pipeline) and Sorrento Therapeutics(Pipeline), etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CAR T-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CAR T-Cell Therapy Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global CAR T-Cell Therapy Market Segment Percentages, by Type, 2022 (%)
CD19 - Targeted
BCMA - Targeted
Global CAR T-Cell Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global CAR T-Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Lymphoma
Multiple Myeloma
Global CAR T-Cell Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global CAR T-Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CAR T-Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CAR T-Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
CARsgen Therapeutics (Pipeline)
Autolus Therapeutics(Pipeline)
Sorrento Therapeutics(Pipeline)
Mustang Bio(Pipeline)
Bluebird Bio(Pipeline)
Cellectis(Pipeline)
Allogene Therapeutics(Pipeline)
Celyad(Pipeline)
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 CAR T-Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global CAR T-Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Therapy Overall Market Size
2.1 Global CAR T-Cell Therapy Market Size: 2022 VS 2030
2.2 Global CAR T-Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top CAR T-Cell Therapy Players in Global Market
3.2 Top Global CAR T-Cell Therapy Companies Ranked by Revenue
3.3 Global CAR T-Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 CAR T-Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies CAR T-Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 CAR T-Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global CAR T-Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 CD19 - Targeted
4.1.3 BCMA - Targeted
4.2 By Type - Global CAR T-Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global CAR T-Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global CAR T-Cell Therapy Revenue, 2023-2030
4.2.3 By Type - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global CAR T-Cell Therapy Market Size, 2022 & 2030
5.1.2 Lymphoma
5.1.3 Multiple Myeloma
5.2 By Application - Global CAR T-Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global CAR T-Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global CAR T-Cell Therapy Revenue, 2023-2030
5.2.3 By Application - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global CAR T-Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global CAR T-Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global CAR T-Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global CAR T-Cell Therapy Revenue, 2023-2030
6.2.3 By Region - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America CAR T-Cell Therapy Revenue, 2018-2030
6.3.2 US CAR T-Cell Therapy Market Size, 2018-2030
6.3.3 Canada CAR T-Cell Therapy Market Size, 2018-2030
6.3.4 Mexico CAR T-Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe CAR T-Cell Therapy Revenue, 2018-2030
6.4.2 Germany CAR T-Cell Therapy Market Size, 2018-2030
6.4.3 France CAR T-Cell Therapy Market Size, 2018-2030
6.4.4 U.K. CAR T-Cell Therapy Market Size, 2018-2030
6.4.5 Italy CAR T-Cell Therapy Market Size, 2018-2030
6.4.6 Russia CAR T-Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries CAR T-Cell Therapy Market Size, 2018-2030
6.4.8 Benelux CAR T-Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia CAR T-Cell Therapy Revenue, 2018-2030
6.5.2 China CAR T-Cell Therapy Market Size, 2018-2030
6.5.3 Japan CAR T-Cell Therapy Market Size, 2018-2030
6.5.4 South Korea CAR T-Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia CAR T-Cell Therapy Market Size, 2018-2030
6.5.6 India CAR T-Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America CAR T-Cell Therapy Revenue, 2018-2030
6.6.2 Brazil CAR T-Cell Therapy Market Size, 2018-2030
6.6.3 Argentina CAR T-Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa CAR T-Cell Therapy Revenue, 2018-2030
6.7.2 Turkey CAR T-Cell Therapy Market Size, 2018-2030
6.7.3 Israel CAR T-Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia CAR T-Cell Therapy Market Size, 2018-2030
6.7.5 UAE CAR T-Cell Therapy Market Size, 2018-2030
7 Players Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis CAR T-Cell Therapy Major Product Offerings
7.1.4 Novartis CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News
7.2 Gilead Sciences
7.2.1 Gilead Sciences Corporate Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences CAR T-Cell Therapy Major Product Offerings
7.2.4 Gilead Sciences CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Gilead Sciences Key News
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Key News
7.4 J & J
7.4.1 J & J Corporate Summary
7.4.2 J & J Business Overview
7.4.3 J & J CAR T-Cell Therapy Major Product Offerings
7.4.4 J & J CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 J & J Key News
7.5 JW Therapeutics
7.5.1 JW Therapeutics Corporate Summary
7.5.2 JW Therapeutics Business Overview
7.5.3 JW Therapeutics CAR T-Cell Therapy Major Product Offerings
7.5.4 JW Therapeutics CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 JW Therapeutics Key News
7.6 FOSUNKite
7.6.1 FOSUNKite Corporate Summary
7.6.2 FOSUNKite Business Overview
7.6.3 FOSUNKite CAR T-Cell Therapy Major Product Offerings
7.6.4 FOSUNKite CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 FOSUNKite Key News
7.7 CARsgen Therapeutics (Pipeline)
7.7.1 CARsgen Therapeutics (Pipeline) Corporate Summary
7.7.2 CARsgen Therapeutics (Pipeline) Business Overview
7.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Major Product Offerings
7.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 CARsgen Therapeutics (Pipeline) Key News
7.8 Autolus Therapeutics(Pipeline)
7.8.1 Autolus Therapeutics(Pipeline) Corporate Summary
7.8.2 Autolus Therapeutics(Pipeline) Business Overview
7.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Autolus Therapeutics(Pipeline) Key News
7.9 Sorrento Therapeutics(Pipeline)
7.9.1 Sorrento Therapeutics(Pipeline) Corporate Summary
7.9.2 Sorrento Therapeutics(Pipeline) Business Overview
7.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Sorrento Therapeutics(Pipeline) Key News
7.10 Mustang Bio(Pipeline)
7.10.1 Mustang Bio(Pipeline) Corporate Summary
7.10.2 Mustang Bio(Pipeline) Business Overview
7.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Mustang Bio(Pipeline) Key News
7.11 Bluebird Bio(Pipeline)
7.11.1 Bluebird Bio(Pipeline) Corporate Summary
7.11.2 Bluebird Bio(Pipeline) Business Overview
7.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 Bluebird Bio(Pipeline) Key News
7.12 Cellectis(Pipeline)
7.12.1 Cellectis(Pipeline) Corporate Summary
7.12.2 Cellectis(Pipeline) Business Overview
7.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Cellectis(Pipeline) Key News
7.13 Allogene Therapeutics(Pipeline)
7.13.1 Allogene Therapeutics(Pipeline) Corporate Summary
7.13.2 Allogene Therapeutics(Pipeline) Business Overview
7.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 Allogene Therapeutics(Pipeline) Key News
7.14 Celyad(Pipeline)
7.14.1 Celyad(Pipeline) Corporate Summary
7.14.2 Celyad(Pipeline) Business Overview
7.14.3 Celyad(Pipeline) CAR T-Cell Therapy Major Product Offerings
7.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Celyad(Pipeline) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. CAR T-Cell Therapy Market Opportunities & Trends in Global Market
Table 2. CAR T-Cell Therapy Market Drivers in Global Market
Table 3. CAR T-Cell Therapy Market Restraints in Global Market
Table 4. Key Players of CAR T-Cell Therapy in Global Market
Table 5. Top CAR T-Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global CAR T-Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global CAR T-Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies CAR T-Cell Therapy Product Type
Table 9. List of Global Tier 1 CAR T-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global CAR T-Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global CAR T-Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global CAR T-Cell Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2030
Table 30. Novartis Corporate Summary
Table 31. Novartis CAR T-Cell Therapy Product Offerings
Table 32. Novartis CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Gilead Sciences Corporate Summary
Table 34. Gilead Sciences CAR T-Cell Therapy Product Offerings
Table 35. Gilead Sciences CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb CAR T-Cell Therapy Product Offerings
Table 38. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 39. J & J Corporate Summary
Table 40. J & J CAR T-Cell Therapy Product Offerings
Table 41. J & J CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 42. JW Therapeutics Corporate Summary
Table 43. JW Therapeutics CAR T-Cell Therapy Product Offerings
Table 44. JW Therapeutics CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 45. FOSUNKite Corporate Summary
Table 46. FOSUNKite CAR T-Cell Therapy Product Offerings
Table 47. FOSUNKite CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 48. CARsgen Therapeutics (Pipeline) Corporate Summary
Table 49. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product Offerings
Table 50. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Autolus Therapeutics(Pipeline) Corporate Summary
Table 52. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product Offerings
Table 53. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Sorrento Therapeutics(Pipeline) Corporate Summary
Table 55. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product Offerings
Table 56. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Mustang Bio(Pipeline) Corporate Summary
Table 58. Mustang Bio(Pipeline) CAR T-Cell Therapy Product Offerings
Table 59. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 60. Bluebird Bio(Pipeline) Corporate Summary
Table 61. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product Offerings
Table 62. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 63. Cellectis(Pipeline) Corporate Summary
Table 64. Cellectis(Pipeline) CAR T-Cell Therapy Product Offerings
Table 65. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 66. Allogene Therapeutics(Pipeline) Corporate Summary
Table 67. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product Offerings
Table 68. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
Table 69. Celyad(Pipeline) Corporate Summary
Table 70. Celyad(Pipeline) CAR T-Cell Therapy Product Offerings
Table 71. Celyad(Pipeline) CAR T-Cell Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. CAR T-Cell Therapy Segment by Type in 2022
Figure 2. CAR T-Cell Therapy Segment by Application in 2022
Figure 3. Global CAR T-Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global CAR T-Cell Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global CAR T-Cell Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2022
Figure 8. By Type - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 12. US CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 16. Germany CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 24. China CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa CAR T-Cell Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE CAR T-Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. Novartis CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Gilead Sciences CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Bristol-Myers Squibb CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. J & J CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. JW Therapeutics CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. FOSUNKite CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Cellectis(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Celyad(Pipeline) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
